PTGX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Protagonist Therapeutics (PTGX) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PTGX is expected to report earnings to fall 82.63% to -9 cents per share on March 18

Protagonist Therapeutics PTGX Stock Earnings Reports

Q4'24

Est.

$-0.09

Q3'24

Beat

by $0.04

Q2'24

Beat

by $0.10

Q1'24

Beat

by $2.07

Q4'23

Beat

by $0.39

The last earnings report on November 08 showed earnings per share of -54 cents, beating the estimate of -57 cents. With 719.22K shares outstanding, the current market capitalization sits at 2.45B.

View a ticker or compare two or three

Compare

PTGX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For PTGX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for PTGX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of disulfide-rich peptides

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

7707 Gateway Boulevard

Phone

+1 510 474-0170

Employees

112

Web

https://www.protagonist-inc.com